FI932012L - Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar - Google Patents

Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar Download PDF

Info

Publication number
FI932012L
FI932012L FI932012A FI932012A FI932012L FI 932012 L FI932012 L FI 932012L FI 932012 A FI932012 A FI 932012A FI 932012 A FI932012 A FI 932012A FI 932012 L FI932012 L FI 932012L
Authority
FI
Finland
Prior art keywords
heterocykliska
arylpiperazinyl
foereningar
foerfarande foer
foer framstaellning
Prior art date
Application number
FI932012A
Other languages
English (en)
Other versions
FI111641B (fi
FI932012A0 (fi
Inventor
Frank R Busch
Paul Bowles
Douglas J M Allen
Sabeto A Diroma
Dennis M Godek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25468285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI932012(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of FI932012A0 publication Critical patent/FI932012A0/fi
Publication of FI932012L publication Critical patent/FI932012L/fi
Application granted granted Critical
Publication of FI111641B publication Critical patent/FI111641B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Eye Examination Apparatus (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Lubricants (AREA)
FI932012A 1992-08-26 1993-05-04 Menetelmä aryylipiperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi FI111641B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93617992 1992-08-26
US07/936,179 US5206366A (en) 1992-08-26 1992-08-26 Process for preparing aryl piperazinyl-heterocyclic compounds

Publications (3)

Publication Number Publication Date
FI932012A0 FI932012A0 (fi) 1993-05-04
FI932012L true FI932012L (fi) 1994-02-27
FI111641B FI111641B (fi) 2003-08-29

Family

ID=25468285

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932012A FI111641B (fi) 1992-08-26 1993-05-04 Menetelmä aryylipiperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi

Country Status (27)

Country Link
US (1) US5206366A (fi)
EP (2) EP0584903B1 (fi)
JP (1) JP2742370B2 (fi)
KR (1) KR0123441B1 (fi)
CN (1) CN1033089C (fi)
AT (2) ATE206422T1 (fi)
AU (1) AU642836B1 (fi)
BR (1) BR9302065A (fi)
CZ (1) CZ281893B6 (fi)
DE (2) DE69330853T2 (fi)
DK (2) DK0584903T3 (fi)
EG (1) EG20214A (fi)
ES (2) ES2225015T3 (fi)
FI (1) FI111641B (fi)
HU (1) HU223312B1 (fi)
IL (1) IL105622A (fi)
MX (1) MX9302813A (fi)
MY (1) MY109731A (fi)
NO (1) NO300685B1 (fi)
NZ (1) NZ247539A (fi)
PL (1) PL173840B1 (fi)
PT (2) PT1029861E (fi)
RU (1) RU2061695C1 (fi)
SI (1) SI9300287A (fi)
SK (1) SK280584B6 (fi)
YU (1) YU48964B (fi)
ZA (1) ZA936225B (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5338846A (en) * 1992-08-26 1994-08-16 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt
US5359068A (en) * 1993-06-28 1994-10-25 Pfizer Inc. Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
HUP9802492A3 (en) * 1995-06-06 1999-10-28 Hoechst Marion Roussel Inc Cin Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
CA2252895C (en) * 1996-05-07 2002-08-20 Pfizer Inc. Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
TW491847B (en) 1996-05-07 2002-06-21 Pfizer Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
TWI242011B (en) * 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US5945421A (en) * 1997-08-11 1999-08-31 Warner-Lambert Company Dopamine D4 receptor antagonists
US6040448A (en) * 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
CA2320757A1 (en) * 1998-03-06 1999-09-10 Astrazeneca Ab New use
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
US6660858B2 (en) 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
US20040048876A1 (en) * 2002-02-20 2004-03-11 Pfizer Inc. Ziprasidone composition and synthetic controls
UY27668A1 (es) 2002-02-20 2003-10-31 Pfizer Prod Inc Composición de ziprasidona y controles sintéticos
AP2005003250A0 (en) * 2002-09-17 2005-03-31 Warner Lambert Co Heterocyclic substituted piperazines for the treatment of schizophrenia.
EP1556378B1 (en) * 2002-10-24 2008-01-09 Pfizer Products Inc. Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
AU2003272030A1 (en) * 2002-11-08 2004-06-07 Warner-Lambert Company Llc Phenylalkyl and pyridylalkyl piperazine derivatives
AU2003300814A1 (en) 2002-12-04 2004-06-23 Dr. Reddy's Laboratories Inc. Polymorphic forms of ziprasidone and its hydrochloride
WO2004050655A1 (en) * 2002-12-04 2004-06-17 Dr. Reddy's Laboratories Limited Polymorphic forms of ziprasidone and its hydrochloride
CN1255105C (zh) * 2002-12-17 2006-05-10 上海医药工业研究院 齐拉西酮及其盐的水溶性包合物及其制备方法
AU2003245027A1 (en) * 2003-04-11 2004-11-01 Hetero Drugs Limited Novel crystalline forms of ziprasidone hydrochloride
KR20080022595A (ko) * 2003-06-03 2008-03-11 테바 파마슈티컬 인더스트리즈 리미티드 지프라시돈 ＨＣｌ의 다형 형태 및 그 제조 방법
US20050049295A1 (en) * 2003-06-12 2005-03-03 Dr. Reddy's Laboratories Limited Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
EP1628973A2 (en) 2003-10-24 2006-03-01 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
CN1934108A (zh) * 2003-12-18 2007-03-21 特瓦制药工业有限公司 齐拉西酮碱的多晶型b2
EP1720867B1 (en) * 2004-02-27 2009-12-09 Ranbaxy Laboratories Limited Process for the preparation of ziprasidone
ITMI20040944A1 (it) * 2004-05-11 2004-08-11 Dinamite Dipharma S P A In For Polimorfo di ziprasidone cloridrato e procedimento per la sua preparazione
CA2467538C (en) * 2004-05-14 2010-08-24 Apotex Pharmachem Inc. New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same
CA2471219A1 (en) * 2004-06-14 2005-12-14 Apotex Pharmachem Inc. Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride)
WO2006011157A2 (en) * 2004-06-18 2006-02-02 Lupin Limited Methods for the preparation of aryl piperazinyl-heterocyclic compounds
WO2006026426A2 (en) * 2004-08-27 2006-03-09 University Of Kentucky Research Foundation Amyloid peptide inactivating enzyme to treat alzheimer’s disease peripherally
ES2250000B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Procedimiento para la preparacion de ziprasidona.
ES2250001B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Proceso para la purificacion de ziprasidona.
US7777037B2 (en) * 2004-10-27 2010-08-17 Dr. Reddy's Laboratories Limited Ziprasidone process
WO2006086779A1 (en) * 2005-02-11 2006-08-17 Teva Pharmaceutical Industries Ltd. Amorphous ziprasidone mesylate
US20060270685A1 (en) * 2005-03-14 2006-11-30 Judith Aronhime Anhydrous ziprasidone mesylate and a process for its preparation
CA2599391A1 (en) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of ziprasidone mesylate
CN101189237A (zh) * 2005-04-01 2008-05-28 沃尼尔·朗伯有限责任公司 用于治疗精神分裂症的四氢－吡啶并氮杂䓬－8－酮和相关化合物
HU230479B1 (hu) * 2006-05-02 2016-07-28 Richter Gedeon Nyrt. Eljárás 5-{2-[4-(1,2-benzizotiazol-3-il)-1-piperazinil]-etil}-6-klór-1,3-dihidro-2H-indol-2-on (Ziprasidon) előállítására
HUP0600868A3 (en) * 2006-11-24 2009-03-30 Richter Gedeon Nyrt 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrogen bromide polimorphs and process for their preparation
WO2009116085A2 (en) * 2008-03-11 2009-09-24 Alkem Laboratories Ltd. An improved process for the preparation of ziprasidone
MX2012013197A (es) 2010-05-12 2013-04-03 Abbvie Inc Inhibidores de indazol de cinasa.
PL391810A1 (pl) 2010-07-14 2012-01-16 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Nowe sole ziprasidonu oraz sposoby ich otrzymywania
WO2012020424A1 (en) 2010-08-12 2012-02-16 Arch Pharmalabs Limited A short process for the preparation of ziprasidone and intermediates thereof
SI23610A (sl) 2011-01-13 2012-07-31 Diagen@d@o@o Nove adicijske soli ziprasidona postopek za njihovo pripravo in njihova uporaba v terapiji

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610988A (en) * 1982-04-09 1986-09-09 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(substituted)piperazines useful for alleviating pain
FR2536749A1 (fr) * 1982-11-25 1984-06-01 Cerm Cent Europ Rech Mauvernay (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride

Also Published As

Publication number Publication date
FI111641B (fi) 2003-08-29
SK280584B6 (sk) 2000-04-10
ATE273976T1 (de) 2004-09-15
SI9300287A (en) 1994-03-31
EP0584903A1 (en) 1994-03-02
US5206366A (en) 1993-04-27
PL299002A1 (en) 1994-03-21
HU9301291D0 (en) 1993-07-28
ATE206422T1 (de) 2001-10-15
HUT65750A (en) 1994-07-28
SK48593A3 (en) 1994-04-06
CZ87793A3 (en) 1994-04-13
BR9302065A (pt) 1994-07-26
MX9302813A (es) 1994-02-28
DE69330853T2 (de) 2002-05-02
EP1029861B1 (en) 2004-08-18
PT584903E (pt) 2002-02-28
PT1029861E (pt) 2004-11-30
CN1033089C (zh) 1996-10-23
KR940003952A (ko) 1994-03-14
RU2061695C1 (ru) 1996-06-10
ES2225015T3 (es) 2005-03-16
KR0123441B1 (ko) 1997-11-24
YU48964B (sh) 2003-01-31
IL105622A (en) 1998-06-15
NZ247539A (en) 1995-09-26
DE69333597D1 (de) 2004-09-23
HU223312B1 (hu) 2004-05-28
NO931656D0 (no) 1993-05-06
JPH06184143A (ja) 1994-07-05
ZA936225B (en) 1995-02-27
JP2742370B2 (ja) 1998-04-22
IL105622A0 (en) 1993-09-22
FI932012A0 (fi) 1993-05-04
YU56593A (sh) 1996-07-24
ES2161703T3 (es) 2001-12-16
NO931656L (no) 1994-02-28
DK0584903T3 (da) 2001-12-03
CN1083061A (zh) 1994-03-02
DE69333597T2 (de) 2005-09-15
AU642836B1 (en) 1993-10-28
CZ281893B6 (cs) 1997-03-12
DE69330853D1 (de) 2001-11-08
EP0584903B1 (en) 2001-10-04
EP1029861A1 (en) 2000-08-23
EG20214A (en) 1997-11-30
MY109731A (en) 1997-05-31
PL173840B1 (pl) 1998-05-29
NO300685B1 (no) 1997-07-07
DK1029861T3 (da) 2004-11-15

Similar Documents

Publication Publication Date Title
FI930507L (fi) Insprutningsanordning och -foerfarande foer insprutning av tillsatsaemnen
FI933619A0 (fi) En mekanism foer jaemn tvinning av en kabeltrumma
FI924590L (fi) Foerfarande foer framstaellning av laekemedelskorn
FI932012L (fi) Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar
FI931372A7 (fi) Foerfarande foer behandling av rumsluft foer maenskor
FI930636L (fi) Foerfarande foer framstaellning av en flerstegspolymer
FI931408A7 (fi) Anordning foer fraesning av amorfiska staolremsor
FI930281L (fi) Reaktivering av hydroformyleringskatalysatorer
FI930644L (fi) Foerfarande foer framstaellning av transdermala laekemedelsavgivningssystem
FI925945L (fi) Avlaegsnande av kvicksilver fraon avfallsvatten
FI931668A0 (fi) Cellrestprodukter av jaest
FI930308L (fi) Foerbaettrat foerfarande foer framstaellning av en kaciumnitrat- ureaaddukt
FI931066A7 (fi) Anordning foer drivning av en insprutningspump
FI931554L (fi) Foerfarande foer utvinning av enzymer fraon proenzymer
FI931677L (fi) Foerfarande foer paovisning av nukleinsyror
FI932714L (fi) Propellermodul foer indikering av stroemning
FI930893L (fi) Anordning foer analysering av kolprodukter
FI930710A7 (fi) Anordning foer oevervakning av vaetskenivao
FI931943L (fi) Foerfarande foer framstaellning av en silvernitratloesning
FI920011L (fi) Av roerformade delar bildat vaeggelement
FI924437L (fi) Roterande tillaeggsanordning foer foerbaettring av wobblerns faongsteffekt
FI930508A7 (fi) Foerfarande foer tydligt utnyttjande av en oeverfoeringsanordning
FI930060A0 (fi) Foerfarande foer framstaellning av optiskt aktiva benzotiazepinfoereningarmed asymmetrisk reduktion
FI931127A0 (fi) Anordning foer behandling av kortformiga databaerare
FI231U1 (fi) Staengselplanka av elementtyp

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20050015